Manuscript Structure
Article Types, Formatting, Referencing, and Declaration Requirements
The International Journal of Pharma Studies accepts several types of scholarly manuscripts in pharmaceutical sciences and related fields. Authors should select the appropriate article type and follow the manuscript preparation, formatting, referencing, and ethical requirements described below.
1. Article Types
Original Research Article
Presents original experimental, analytical, theoretical, observational, clinical, or applied pharmaceutical research with clear findings and a meaningful scientific contribution. Topics may include drug formulation, drug delivery, pharmacology, pharmaceutical chemistry, pharmacognosy, pharmaceutical analysis, and drug development.
Recommended length: 4,000–12,000 words
Review Article
Provides a comprehensive and critical review of existing pharmaceutical research on a specific topic, including major scientific developments, research gaps, therapeutic applications, and future directions.
Recommended length: 5,000–15,000 words
Case Study / Case Report
Provides a detailed examination of a relevant pharmaceutical or clinical pharmacy case, medication-related problem, adverse drug reaction, pharmaceutical practice, or other appropriate scientific subject. Clinical case reports must meet applicable ethical, consent, and confidentiality requirements.
Recommended length: 3,000–8,000 words
Short Communication / Research Note
Presents concise and significant pharmaceutical research findings, preliminary experimental results, analytical method developments, formulation observations, or focused scientific contributions.
Recommended length: 2,000–4,000 words
Conceptual / Theoretical Article
Discusses or develops concepts, theories, models, frameworks, or theoretical perspectives relevant to pharmaceutical sciences, drug discovery, pharmaceutical technology, medication safety, or healthcare-related pharmaceutical research.
Recommended length: 3,000–10,000 words
Perspective / Commentary
Provides a scholarly discussion or informed perspective on important pharmaceutical, clinical, regulatory, methodological, or emerging scientific issues, including advances in drug development, pharmacovigilance, pharmaceutical biotechnology, and pharmacy practice.
Recommended length: 1,500–4,000 words
The recommended word counts are flexible guidelines and may vary according to the nature, methodology, scientific content, and requirements of the manuscript.
2. Manuscript Formatting
Manuscripts should normally be submitted as Microsoft Word (.docx) files, unless an alternative format or template is specified by the International Journal of Pharma Studies.
| Requirement | Recommended format |
|---|---|
| Page size | A4 |
| Margins | Approximately 2.54 cm (1 inch) |
| Main text | Times New Roman, 10-point, double-spaced |
| Article title | Times New Roman, 16-point, bold |
| Author names and affiliations | Times New Roman, 12-point |
| Page numbers | Consecutive |
| Headings | Clear and consistent |
| Tables | Editable format where possible |
| Figures and scientific images | Clear and suitable for publication |
| Chemical structures, graphs, and analytical plots | Clearly labelled and legible |
Authors should use the official journal manuscript template where provided.
Pharmaceutical and experimental studies should include sufficient methodological information to support scientific evaluation and reproducibility. Where applicable, authors should identify the analytical instruments, reagents, reference standards, experimental conditions, validation procedures, statistical methods, and relevant software used in the study.
3. Author Information
Each manuscript should include the full article title, names of all authors, institutional affiliations and country, ORCID iDs where available, and the corresponding author's email address.
All authors must be entered accurately in the online submission system. The corresponding author is responsible for communication with the journal and should confirm that all authors have reviewed and approved the manuscript.
4. Abstract and Keywords
Most manuscripts should include an abstract of approximately 150–300 words, briefly presenting the research background or problem, objective, methodology, principal findings, and conclusion or scientific significance.
For experimental pharmaceutical research, the abstract should summarize the study design, important experimental or analytical methods, key results, and major conclusions where applicable.
Authors should provide 3–8 relevant keywords that accurately describe the subject of the manuscript and support academic search and discovery. Keywords may include relevant pharmaceutical compounds, drug delivery approaches, therapeutic areas, analytical techniques, or pharmaceutical research methods.
5. Manuscript Structure
The structure should be appropriate to the article type and pharmaceutical research methodology. A typical original research article may follow this sequence:
For pharmaceutical studies, the Materials and Methods section should provide sufficient information about experimental design, materials, procedures, analytical methods, and statistical analysis to support scientific assessment and reproducibility.
Clinical studies, systematic reviews, laboratory investigations, and other specialized research may require different structures or additional reporting elements. Authors should use a clear and logical organization appropriate to their research.
6. References
The International Journal of Pharma Studies follows the Vancouver reference style, unless otherwise specified for a particular article.
Authors should ensure that:
Accurate references help ensure proper scholarly attribution, scientific traceability, and reliable academic discoverability.
7. Figures, Tables, and Supplementary Materials
Figures and tables should be numbered consecutively and cited in the text, each with a clear and informative title or caption.
Photographs and experimental images should generally be provided at 300 dpi or higher, and line drawings at 600 dpi or higher. Tables should remain editable where possible.
Graphs, chromatograms, spectra, microscopy images, chemical structures, formulation diagrams, and other scientific illustrations should be clear, appropriately labelled, and consistent with the reported findings. Authors must not manipulate or selectively alter scientific images in ways that misrepresent the underlying research.
Authors are responsible for obtaining permission and providing appropriate attribution for any copyrighted third-party material.
Supplementary materials—such as datasets, additional tables or figures, analytical validation results, experimental protocols, questionnaires, code, or other supporting research files—may be submitted where relevant and should be clearly identified and cited.
8. Declarations
Where applicable, manuscripts should include the following statements:
For example:
Funding: This research received no external funding.
Conflict of Interest: The authors declare that they have no conflict of interest.
Data Availability: The data supporting the findings of this study are available from the corresponding author upon reasonable request, subject to applicable restrictions.
Statements should be included only when they accurately reflect the circumstances of the research. Authors should not use a sample declaration if it does not apply to their study.
Research involving human participants, clinical trials, patient records, biological samples, animals, or other sensitive information must comply with applicable ethical and regulatory requirements. Relevant ethics approval, informed consent, privacy protections, and trial registration details should be provided where required.
9. Authorship and ORCID
Authorship should reflect a substantial scholarly contribution to the research and manuscript. All listed authors should approve the submitted manuscript and its final version.
Contributors who do not meet the applicable authorship criteria may be acknowledged separately.
Any change to the author list after submission should be supported by a written explanation and confirmation from all affected authors, in accordance with the journal's authorship policy.
Authors are strongly encouraged to provide ORCID iDs to support accurate author identification and scholarly attribution.